Sectoral Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Sectoral Asset Management’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-109,211	Closed	-$1.81M	–	86
2015 Q3	$1.81M	Sell	109,211 -1,260,323	-92%	-$25.3M	0.08%	62
2015 Q2	$30.8M	Sell	1,369,534 -164,044	-11%	-$4.05M	1.29%	23
2015 Q1	$39.5M	Sell	1,533,578 -64,715	-4%	-$1.64M	1.5%	25
2014 Q4	$34.8M	Sell	1,598,293 -96,224	-6%	-$1.97M	1.56%	25
2014 Q3	$32.1M	Buy	1,694,517 +302,032	+22%	+$6.07M	1.35%	25
2014 Q2	$32.4M	Buy	1,392,485 +44,843	+3%	+$1.11M	1.37%	29
2014 Q1	$45.3M	Buy	1,347,642 +127,636	+10%	+$4.3M	1.87%	21
2013 Q4	$36M	Buy	1,220,006 +160,527	+15%	+$2.94M	1.55%	25
2013 Q3	$16.2M	Buy	+1,059,479	New	+$19.6M	0.78%	40

Other funds holding OMED

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sectoral Asset Management's OMED Position: Q4 2015 in Review

Sectoral Asset Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q4 2015, closing a stake of 109,211 shares — an estimated $1.81M sold.

Sectoral Asset Management first reported a position in OMED in Q3 2013 and held it in 9 quarters. The position peaked at $45.3M in Q1 2014. 83 funds tracked by Wall St. Rank hold OMED as of Q4 2015.

Sectoral Asset Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
Sectoral Asset Management sold 109,211 OncoMed Pharmaceuticals, Inc. shares in Q4 2015, an estimated $1.81M.
Sectoral Asset Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 9 quarters.
Sectoral Asset Management's OncoMed Pharmaceuticals, Inc. position peaked at $45.3M in Q1 2014.
83 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2015.

Based on Sectoral Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.